JP2022544613A5 - - Google Patents
Info
- Publication number
- JP2022544613A5 JP2022544613A5 JP2022509723A JP2022509723A JP2022544613A5 JP 2022544613 A5 JP2022544613 A5 JP 2022544613A5 JP 2022509723 A JP2022509723 A JP 2022509723A JP 2022509723 A JP2022509723 A JP 2022509723A JP 2022544613 A5 JP2022544613 A5 JP 2022544613A5
- Authority
- JP
- Japan
- Prior art keywords
- hepatitis
- vaccine
- unit dose
- dengue
- dengue fever
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024177535A JP2025032070A (ja) | 2019-08-16 | 2024-10-09 | デング熱及びa型肝炎を予防するための方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IDP00201907241 | 2019-08-16 | ||
| IDPID2019-07241 | 2019-08-16 | ||
| EP19195692.9 | 2019-09-05 | ||
| USPCT/US2019/049749 | 2019-09-05 | ||
| US16/561,953 US11590221B2 (en) | 2018-09-05 | 2019-09-05 | Dengue vaccine unit dose and administration thereof |
| EP19195692.9A EP3620174B1 (en) | 2018-09-05 | 2019-09-05 | Dengue vaccine unit dose and administration thereof |
| PCT/US2019/049749 WO2020051334A1 (en) | 2018-09-05 | 2019-09-05 | Dengue vaccine unit dose and administration thereof |
| US16/561,953 | 2019-09-05 | ||
| PCT/US2020/020991 WO2021034349A1 (en) | 2019-08-16 | 2020-03-04 | Methods for preventing dengue and hepatitis a |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024177535A Division JP2025032070A (ja) | 2019-08-16 | 2024-10-09 | デング熱及びa型肝炎を予防するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544613A JP2022544613A (ja) | 2022-10-19 |
| JP2022544613A5 true JP2022544613A5 (cg-RX-API-DMAC7.html) | 2023-03-09 |
| JP7731344B2 JP7731344B2 (ja) | 2025-08-29 |
Family
ID=74660757
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509723A Active JP7731344B2 (ja) | 2019-08-16 | 2020-03-04 | デング熱及びa型肝炎を予防するための方法 |
| JP2024177535A Pending JP2025032070A (ja) | 2019-08-16 | 2024-10-09 | デング熱及びa型肝炎を予防するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024177535A Pending JP2025032070A (ja) | 2019-08-16 | 2024-10-09 | デング熱及びa型肝炎を予防するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4013451A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7731344B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220049023A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114555113A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2020331884B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001476A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3147807A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022001742A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12022550261A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021034349A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260167703A1 (en) * | 2022-11-02 | 2026-06-18 | Takeda Vaccines, Inc. | A method for determining the infectivity of a virus |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2345614T3 (es) | 1997-02-28 | 2010-09-28 | Sanofi Pasteur Biologics Co. | Vacunas quimericas de flavivirus. |
| AU2003239932A1 (en) | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| WO2007021672A2 (en) | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| FR2903605A1 (fr) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| DK2054428T3 (da) | 2006-08-15 | 2013-08-26 | Government Of The U S A As Repr By The Secretary Dept Of Health & Human Services The Nat Inst Of Hea | Udvikling af bestanddele til denque-virus-vaccine |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| EP2931310A4 (en) * | 2012-12-14 | 2016-05-25 | Takeda Vaccines Inc | COMPOSITIONS, METHODS OF ADMINISTRATION AND USES OF TRIVALENT FORMULATIONS AGAINST DENGUE VIRUS |
| TWI852899B (zh) * | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| EP3316905A1 (en) * | 2015-07-03 | 2018-05-09 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| JP2019511533A (ja) * | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| TWI766876B (zh) | 2016-08-03 | 2022-06-11 | 美商武田疫苗股份有限公司 | 用於與經改良之調配物一起穩定黃病毒的組成物及方法 |
-
2020
- 2020-03-04 WO PCT/US2020/020991 patent/WO2021034349A1/en not_active Ceased
- 2020-03-04 PH PH1/2022/550261A patent/PH12022550261A1/en unknown
- 2020-03-04 AU AU2020331884A patent/AU2020331884B2/en active Active
- 2020-03-04 EP EP20719243.6A patent/EP4013451A1/en active Pending
- 2020-03-04 MX MX2022001742A patent/MX2022001742A/es unknown
- 2020-03-04 KR KR1020227008716A patent/KR20220049023A/ko active Pending
- 2020-03-04 CN CN202080071928.2A patent/CN114555113A/zh active Pending
- 2020-03-04 JP JP2022509723A patent/JP7731344B2/ja active Active
- 2020-03-04 BR BR112022001476A patent/BR112022001476A2/pt unknown
- 2020-03-04 CA CA3147807A patent/CA3147807A1/en active Pending
-
2024
- 2024-10-09 JP JP2024177535A patent/JP2025032070A/ja active Pending
-
2025
- 2025-04-23 AU AU2025202876A patent/AU2025202876B2/en active Active
-
2026
- 2026-04-15 AU AU2026202847A patent/AU2026202847A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stevens et al. | Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission | |
| Mitus et al. | Attenuated measles vaccine in children with acute leukemia | |
| Ni et al. | Hepatitis B vaccination in children: the Taiwan experience | |
| Zhang et al. | Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine | |
| Stevens et al. | Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization | |
| Parkman et al. | Summary of clinical trials of influenza virus vaccines in adults | |
| Ghendon | WHO strategy for the global elimination of new cases of hepatitis B | |
| US10092640B2 (en) | Combination heptavalent vaccine | |
| Xu et al. | Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection | |
| SI9300271A (en) | Combinated vaccine combinations containing hepatitis b as a vaccine component useful for treating hepatitis b infections | |
| JP2016020361A (ja) | ワクチン | |
| Esposito et al. | Hexavalent vaccines for immunization in paediatric age | |
| CN105473603B (zh) | 用于登革病毒疫苗的方法与组合物 | |
| Dennehy | Active immunization in the United States: developments over the past decade | |
| Nirmal et al. | Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine | |
| Ward et al. | Hepatitis B vaccines | |
| Gil et al. | Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL. U.). A controlled study in adults | |
| EP1187631B1 (en) | Prevention of type 1 diabetes and other non-polio enterovirus diseases | |
| US7972592B2 (en) | Prevention of type 1 diabetes and other non-polio enterovirus diseases | |
| Doerr et al. | Vaccination against infectious diseases: what is promising? | |
| Sonoyama et al. | Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults | |
| Kollaritsch et al. | Principles of immunization | |
| JP2020536107A5 (cg-RX-API-DMAC7.html) | ||
| Sumaya et al. | Persistence of antibody after the administration of influenza vaccine to children with cancer | |
| Ward | Hepatitis B vaccines |